Daniel P. Kelly
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Physiology top 10%
- Clinical Biochemistry top 5%
- Surgery
- Co-authors
- Philip M. BargerAlison J. WhelanN. GregersenL. DorlandArnold W. StraussGary A. BellusSylvain BrunetNoriko Niwa
- Topics
- Peroxisome Proliferator-Activated Receptors (4 papers)Cardiovascular Function and Risk Factors (3 papers)Mitochondrial Function and Pathology (2 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Daniel P. Kelly
12 papers receiving 688 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 452
- Cardiology and Cardiovascular Medicine 339
- Physiology 219
- Clinical Biochemistry 105
- Surgery 56
Countries citing papers authored by Daniel P. Kelly
This map shows the geographic impact of Daniel P. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Kelly more than expected).
Fields of papers citing papers by Daniel P. Kelly
This network shows the impact of papers produced by Daniel P. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Kelly. The network helps show where Daniel P. Kelly may publish in the future.
Co-authorship network of co-authors of Daniel P. Kelly
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Kelly. A scholar is included among the top collaborators of Daniel P. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Kelly. Daniel P. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | Fetal PGC-1 alpha Overexpression Programs Adult Pancreatic beta-Cell Dysfunction | 2 |
| 6 | 13 | |
| 7 | 32 | |
| 8 | 10 | |
| 9 | 2 | |
| 10 | 401 | |
| 11 | 149 | |
| 12 | 80 |
About Daniel P. Kelly
Daniel P. Kelly is a scholar working on Clinical Biochemistry, Developmental Neuroscience and Emergency Medicine, having authored 12 papers that have together received 707 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Clinical Biochemistry (105 citations), Cardiology and Cardiovascular Medicine (339 citations) and Physiology (219 citations). Daniel P. Kelly has collaborated with scholars based in United States and France. Frequent co-authors include Philip M. Barger, Alison J. Whelan, N. Gregersen, L. Dorland, Arnold W. Strauss, Gary A. Bellus, Sylvain Brunet, Noriko Niwa, Franck Aimond and Céline Marionneau. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.